NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 61 filers reported holding NUVALENT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,154,589 | -92.1% | 15,220 | -92.2% | 0.00% | -100.0% |
| Q1 2024 | $14,653,213 | +16.7% | 195,142 | +14.4% | 0.00% | 0.0% |
| Q4 2023 | $12,554,380 | +30.9% | 170,599 | -18.3% | 0.00% | 0.0% |
| Q3 2023 | $9,593,341 | +64.8% | 208,687 | +51.2% | 0.00% | +50.0% |
| Q2 2023 | $5,820,051 | +162.5% | 138,014 | +85.4% | 0.00% | +100.0% |
| Q4 2022 | $2,216,794 | +35.6% | 74,439 | -11.5% | 0.00% | 0.0% |
| Q3 2022 | $1,635,000 | – | 84,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $1,516,519,081 | 25.23% |
| Bain Capital Life Sciences Investors, LLC | 2,697,267 | $204,614,675 | 22.46% |
| Fairmount Funds Management LLC | 1,924,626 | $146,002,128 | 16.50% |
| Paradigm Biocapital Advisors LP | 4,571,678 | $346,807,493 | 13.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 465,710 | $35,328,761 | 8.34% |
| COMMODORE CAPITAL LP | 1,487,756 | $112,861,170 | 7.70% |
| Perceptive Advisors | 2,549,077 | $193,372,981 | 4.66% |
| Boxer Capital, LLC | 1,120,192 | $84,977,765 | 4.48% |
| First Turn Management, LLC | 252,276 | $19,137,657 | 3.11% |
| Ikarian Capital, LLC | 151,601 | $11,500,452 | 2.00% |